October 3, 2025BioengineeringOpen Access

Gene Therapy for Wet Age-Related Macular Degeneration

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Gene therapy shows potential to enhance treatment outcomes for wet AMD, suggesting new therapeutic options are on the horizon.

Gene therapy could provide more durable solutions for wet AMD, improving patient quality of life.
The prevalence of wet AMD is projected to reach 82 million by 2050, underscoring urgent needs for innovative treatments.
Advancements in gene therapy's biomechanism may facilitate more sustainable treatment options in the near future.
Ongoing trials are crucial for validating gene therapy as a viable treatment for wet AMD.

Barthelemy et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark